Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dr. Reddy's Laboratories Ltd ADR (RDY)

Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dr. Reddy's Laboratories Ltd ADR 8-2-337 ROAD NO.3 BANJARA HILLS HYDERABAD K7 500-034 IND

www.drreddys.com Employees: 27,811 P: 91-40-4900-2900 F: 404-900-2999

Sector:

Medical

Description:

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.

Key Statistics

Overview:

Market Capitalization, $K 11,234,174
Enterprise Value, $K 11,609,174
Shares Outstanding, K 834,634
Float, K 817,941
% Float 98.00%
Short Interest, K 13,730
Short Float 1.64%
Days to Cover 6.42
Short Volume Ratio 0.60
% of Insider Shareholders 2.00%
% of Institutional Shareholders 3.85%

Financials:

Annual Sales, $ 3,811 M
Annual Net Income, $ 663,000 K
Last Quarter Sales, $ 977,400 K
Last Quarter Net Income, $ 135,500 K
EBIT, $ 763,120 K
EBITDA, $ 963,120 K

Growth:

1-Year Return 4.24%
3-Year Return 14.46%
5-Year Return 5.29%
5-Year Revenue Growth 64.55%
5-Year Earnings Growth 41.07%
5-Year Dividend Growth 60.00%

Per-Share Information:

Most Recent Earnings 0.16 on 01/21/26
Next Earnings Date 05/08/26
Earnings Per Share ttm 0.77
EPS Growth vs. Prev Qtr -15.79%
EPS Growth vs. Prev Year -20.00%
Annual Dividend & Yield (Paid) 0.07 (0.53%)
Annual Dividend & Yield (Fwd) 0.07 (0.53%)
Most Recent Dividend 0.071 on 07/25/25
Next Ex-Dividends Date 07/25/25
Dividend Payable Date 08/06/12
Dividend Payout Ratio 9.20%
Most Recent Split 5-1 on 11/05/24

RDY Ratios

Ratio
Price/Earnings ttm 17.51
Price/Earnings forward 21.06
Price/Earnings to Growth 12.25
Return-on-Equity % 15.89%
Return-on-Assets % 10.73%
Profit Margin % 17.40%
Debt/Equity 0.18
Price/Sales 2.95
Price/Cash Flow 13.05
Price/Book 2.69
Book Value/Share 5.01
Interest Coverage 28.27
60-Month Beta 0.34

RDY Dividends

Date Value
07/25/25 $0.0710
07/30/24 $0.4040
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.